Chemotherapy and Radiation
710 articles
Targeting a KRAS Variant in Advanced Pancreatic Cancer
Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer
A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.
A New Combination Chemotherapy Before Surgery
A new clinical trial adds vitamin D to standard of care chemotherapy before surgery, to make pancreatic cancer tumors more removable.
Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet
A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.
A New Immunotherapy Drug to Make Chemotherapy More Effective for Metastatic Pancreatic Cancer
Researchers are testing a new immunotherapy drug to make standard chemotherapy more effective for metastatic pancreatic cancer.
Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer
A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
mRNA Vaccine Trial Expands to Numerous Locations
The mRNA vaccine trial spearheaded by Dr. Vinod Balachandran has opened in more locations in the US and around the world.
Traveling with Pancreatic Cancer
Drs. Sunil Hingorani and David Zhen outline the ways to make traveling with pancreatic cancer easier if you are in treatment.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
A Maintenance Trial for Patients with BRCA or PALB2 Mutations
A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.
The First Line of Defense against Pancreatic Cancer
Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.